Overview

Evaluation of Ocular Comfort With ISTA Tears vs Systane

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)
Phase:
N/A
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions